Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
mental disorder
|
| gptkbp:affects |
gptkb:Animalia
cognition emotion |
| gptkbp:alsoKnownAs |
schizophrenia
|
| gptkbp:associatedWith |
substance abuse
suicide risk dopamine dysregulation glutamate dysfunction impaired social cognition |
| gptkbp:cause |
social withdrawal
impaired occupational functioning reduced quality of life |
| gptkbp:characterizedBy |
hallucinations
delusions disorganized thinking negative symptoms |
| gptkbp:diagnosedBy |
gptkb:DSM-5_criteria
clinical assessment |
| gptkbp:differentialDiagnosis |
gptkb:schizoaffective_disorder
bipolar disorder major depressive disorder with psychotic features |
| gptkbp:firstDescribed |
gptkb:Emil_Kraepelin
|
| gptkbp:firstNamedBy |
gptkb:Eugen_Bleuler
|
| https://www.w3.org/2000/01/rdf-schema#label |
Disorder, Schizophrenic
|
| gptkbp:ICD-10_code |
F20
|
| gptkbp:onset |
early adulthood
late adolescence |
| gptkbp:prevalence |
about 1% of population
|
| gptkbp:prognosis |
episodic
variable chronic |
| gptkbp:riskFactor |
genetic predisposition
environmental factors prenatal stress |
| gptkbp:subspecies |
paranoid schizophrenia
catatonic schizophrenia disorganized schizophrenia residual schizophrenia undifferentiated schizophrenia |
| gptkbp:symptom |
gptkb:anhedonia
paranoia auditory hallucinations alogia avolition flat affect |
| gptkbp:treatment |
cognitive behavioral therapy
antipsychotic medication psychosocial therapy |
| gptkbp:bfsParent |
gptkb:D012852
|
| gptkbp:bfsLayer |
7
|